These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3061171)

  • 1. [Thymus hormones in the immunotherapy of malignant neoplasms (a review of the literature)].
    Nikol'skiĭ IS
    Vrach Delo; 1988 Aug; (8):77-82. PubMed ID: 3061171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interleukin-2 and cancer immunotherapy].
    Ogarkov VI; Dobkin AI; Ryzhova EV; Okulov VB; Kiselev OI
    Vopr Onkol; 1989; 35(2):141-50. PubMed ID: 2648678
    [No Abstract]   [Full Text] [Related]  

  • 3. The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.
    Talmadge JE; Herberman RB
    Cancer Treat Rep; 1986 Jan; 70(1):171-82. PubMed ID: 3510733
    [No Abstract]   [Full Text] [Related]  

  • 4. The gene therapy of cancer: transgenic immunotherapy.
    Zwiebel JA; Su N; MacPherson A; Davis T; Ojeifo JO
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):119-28; discussion 129. PubMed ID: 8303305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental and clinical study of a new immunoregulator preparation thymalin].
    Khavinson VKh; Morozov VG
    Voen Med Zh; 1982 May; (5):37-9. PubMed ID: 7048731
    [No Abstract]   [Full Text] [Related]  

  • 6. Thymic hormone in the treatment of cancer.
    Dardeene M; Bach JF
    Prog Clin Biol Res; 1989; 288():363-82. PubMed ID: 2654955
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunotherapy of malignant diseases].
    Dorval T; Michon J; Tartour E; Fridman WH
    Bull Cancer; 1995; 82 Suppl 2():127s-138s. PubMed ID: 7542946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective uses of thymic hormones in cancer.
    Trainin N; Handzel ZT; Zaizov R
    Prog Clin Biol Res; 1983; 132E():297-304. PubMed ID: 6685874
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunocorrective therapy in the combined treatment of periodontitis patients].
    Dereĭko LV
    Stomatologiia (Mosk); 1987; 66(1):32-4. PubMed ID: 3470984
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states].
    Grinevich IuA; Kamenets LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):9-15. PubMed ID: 390944
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of thymus cytomedins (thymalin) on the course of skin diseases].
    Shaposhnikov OK; Gorbunov VF; Shchedrin VI; Karachunova TN; Vorob'ev VM
    Vestn Dermatol Venerol; 1987; (4):4-7. PubMed ID: 3604444
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunity and immunosuppression in tumor growth].
    Govallo VI
    Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-immunologic evaluation of thymotropin efficacy in dermatosis patients].
    Khamidov ShA; Keremet VV
    Vestn Dermatol Venerol; 1988; (10):7-10. PubMed ID: 3223060
    [No Abstract]   [Full Text] [Related]  

  • 15. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increase of the life span and decrease in the tumor incidence in C3H/Sn mice as affected by thymus and epiphysis polypeptide factors].
    Anisimov VN; Morozov VG; Khavinson VKh
    Dokl Akad Nauk SSSR; 1982; 263(3):742-5. PubMed ID: 6978806
    [No Abstract]   [Full Text] [Related]  

  • 17. [Corynebacteria--stimulators of antitumor resistance].
    Zatula DG; Zaval'niuk AK; Tofan AV
    Eksp Onkol; 1984; 6(6):12-8. PubMed ID: 6396064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interleukin 2].
    Voĭtenok NN
    Ter Arkh; 1988; 60(5):42-6. PubMed ID: 3051488
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
    Oka Y; Tsuboi A; Sugiyama H
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
    [No Abstract]   [Full Text] [Related]  

  • 20. [The immunomodulator thymalin in the experimental chemotherapy of tumors].
    Amosova EN; Iaremenko KV; Cherdyntseva NV; Nikolin VP; Ogreba VI
    Vopr Onkol; 1987; 33(10):68-72. PubMed ID: 3686911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.